Mindpeak Joins Techcyte Fusion Partner Program to Accelerate AI-Powered Digital Pathology

July 11, 2025

Mindpeak is proud to announce its new collaboration with Techcyte, a leading provider of AI-driven digital diagnostics, by joining the Techcyte Fusion™ Partner Program. This partnership brings together two pioneers in artificial intelligence for pathology, united by a mission to enhance diagnostic accuracy, efficiency, and reproducibility in cancer research and diagnostics.

Supporting Labs with Seamless AI Integration

Mindpeak’s suite of AI tools—including Research Use Only (RUO) algorithms for breast, prostate, and gastric cancer, alongside advanced IHC marker analysis—will now be available through the Techcyte Fusion™ platform. By integrating Mindpeak’s robust, explainable AI models, labs worldwide can benefit from interoperable solutions that fit naturally into existing workflows, supporting reproducible research and streamlined daily operations.

“We built Mindpeak to support pathologists with reliable, explainable AI that integrates effortlessly into daily routines,” said Felix Faber, Founder and CEO of Mindpeak. “Partnering with Techcyte allows us to reach more labs with a shared commitment to transforming cancer diagnostics through high-quality, scalable solutions.”

A Shared Vision for the Future of Pathology

The partnership underscores a shared vision: driving the future of digital pathology through validated, workflow-based AI. As labs face growing complexity and demand, collaborations like this will play a critical role in enabling faster, more precise insights and ultimately improving patient care.

Learn More
https://www.einpresswire.com/article/830144303/mindpeak-joins-techcyte-fusion-partner-program-to-accelerate-ai-powered-digital-pathology

‍

Press Release

Related reading

Press Release

8 min read

Accelerating AI Adoption in Pathology: Mindpeak x PathGroup

The role of AI in pathology isn’t just evolving – it’s accelerating. It’s helping pathologists turn complex data into faster, more consistent answers for patients. At Mindpeak, we’re proud to be part of that change. Today, we’re taking another big step forward through a new collaboration with PathGroup – one of the leading providers of anatomic, clinical, molecular and digital pathology services in the U.S.

This partnership goes beyond collaboration; it marks a powerful step toward bringing AI into everyday diagnostics. By combining Mindpeak’s proprietary image analysis technology with PathGroup’s extensive, pathologist-led network, we’re laying the groundwork for a new era of precision and efficiency in pathology.

Together, we’ll support pathologists integrate AI seamlessly into their workflows – enhancing speed, consistency and equity in diagnostics. The result: faster, more reliable insights for patients and more time for pathologists to focus on what matters most – patient care.

At Mindpeak, we believe the future of pathology is AI-augmented, not AI-replaced. Through partnerships like this, that future is becoming reality – one slide at a time.

‍

PhenoScout AI: Advancing mIF Analysis

We’re proud to introduce PhenoScout AI, our next-generation multiplex immunofluorescence (mIF) analysis solution.

By automating phenotype identification, biomarker quantification, and spatial readouts, PhenoScout AI reduces variability and supports large-scale studies. The solution is designed for pharma, diagnostics, and academic research to accelerate translational medicine.

👉 Learn more

‍

Press Release

8 min read

Mindpeak Welcomes Christiaan Neeleman to the Board of Directors

We are delighted to announce that Christiaan Neeleman has joined Mindpeak’s Board of Directors.

With more than 20 years of international leadership experience in life sciences, diagnostics, and health technology - including senior roles at Discovery Life Sciences, Definiens, and Philips Healthcare - Christiaan brings deep expertise that will help accelerate our global expansion.

His proven track record in biomarker development, companion diagnostics, and scaling precision diagnostics businesses aligns perfectly with Mindpeak’s mission: enabling faster, more accurate cancer diagnostics through AI-powered pathology.

We are excited to collaborate with Christiaan as we strengthen partnerships, expand into new markets, and further drive the adoption of AI across clinical and research settings.

Read the full press release here

‍

Ready to advance your diagnostics

Connect with our team to explore how precision pathology works in your setting

Request consult